Decrypt October 20, 2026

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
Source: Decrypt
Back to News

You might also like

Mark Zuckerberg Meta AI Predicts ‘Will Crypto Rec…
Nov 08, 2026 Read
This Bitcoin Developer’s Idea Would Make Quantum …
Nov 08, 2026 Read
Binance France emails announce closure of its use…
Nov 08, 2026 Read
These Finland homes get free heat from bitcoin mi…
Nov 08, 2026 Read